Mithra Pharmaceuticals : Releases 2021 Annual Report

Mithra Releases 2021 Annual Report

Liege, Belgium, 15 April 2022 - 7:30 CEST - Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health today announces the publication of its 2021 Annual Report.

The Annual Report which outlines Mithra's achievements in 2021 includes the following information:

• - Overview of Mithra's R&D pipeline and letter to shareholders;

• - Highlights of Mithra's strategy and outlook for 2022;

• - Brand new section dedicated to Mithra's ESG strategy;

• - Management report;

• - Remuneration report;

• - Financial statements and notes.

The Annual Report is available in English and French and can be read (or downloaded in PDF) on the websitereport2021.mithra.com or oninvestors.mithra.com.

********

For more information, please contact:

Benoît Mathieu (IRO) : [phone] [e-mail] Maud Vanderthommen (Press) : [phone] [e-mail]

About Mithra

Mithra (Euronext: MITRA) is a Belgian biotech company dedicated to transforming Women's Health by offering new choices through innovation, with a particular focus on contraception and menopause. Mithra's goal is to develop products offering better efficacy, safety and convenience, meeting women's needs throughout their life span. Mithra explores the potential of the unique native estrogen estetrol in a wide range of applications in women health and beyond. After having successfully launched the first estetrol-based product in 2021, the contraceptive pill Estelle®, Mithra is now focusing on its second product Donesta®, the next-generation hormone therapy. Mithra also develops and manufactures complex therapeutics in the areas of contraception, menopause and hormone-dependent cancers. It offers partners a complete spectrum of research, development and specialist manufacturing at its technological platform Mithra CDMO. Active in more than 100 countries around the world, Mithra has an approximate headcount of 300 staff members and is headquartered in Liège, Belgium.www.mithra.com

Important information

The contents of this announcement include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the words "believes", "estimates," "anticipates", "expects", "intends", "may", "will", "plans", "continue", "ongoing", "potential", "predict", "project", "target", "seek" or "should", and include statements the Company makes concerning the intended results of its strategy. By their nature, forward-looking statements involve risks and

• • 1

uncertainties and readers are cautioned that any such forward-looking statements are not guarantees of future performance. The Company's actual results may differ materially from those predicted by the forward-looking statements. The Company undertakes no obligation to publicly update or revise forward-looking statements, except as may be required by law.

Subscribe to our mailing list oninvestors.mithra.com to receive our press releases by email or follow us on our social media :

LinkedIn •Twitter •Facebook

• • 2